| Dr Joseph William Vincent, OD | |
|
523 9th St S, Great Falls, MT 59405-2113 | |
| (307) 679-6832 | |
| Not Available |
| Full Name | Dr Joseph William Vincent |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 14 Years |
| Location | 523 9th St S, Great Falls, Montana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265747281 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 2674 (Oklahoma) | Secondary |
| 152W00000X | Optometrist | 825 (Montana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Joseph W. Vincent O.d. And Justine E. Redlin O.d. Vision Care P.c. | 5799957858 | 3 |
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Following publication of an article in the February 18 issue of the New England Journal of Medicine (Vol. 362 No. 7 pp 590-599) by Bibbins-Domingo, et al. that projected the effect of moderate dietary salt reductions on future cardiac disease rates, several members of the American Thyroid Association, concerned about the subsequent potential reduction in availability of iodine, have responded with a letter in the current issue of the NEJM (Vol. 362 No. 23 pp 2224-2226).
Belkin today announced a strategic partnership with Peerless Industries, Inc., a designer, manufacturer and distributor of audio-visual solutions. The partnership will initially yield the PeerCare Electronic Medical Records (EMR) Hybrid Cart, fitted with a unique modular battery power system.
In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) today launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.
› Verified 9 days ago
| Provider Name | Joseph W. Vincent O.d. And Justine E. Redlin O.d. Vision Care P.c. |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1538448592 PECOS PAC ID: 5799957858 Enrollment ID: O20111013000544 |
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Following publication of an article in the February 18 issue of the New England Journal of Medicine (Vol. 362 No. 7 pp 590-599) by Bibbins-Domingo, et al. that projected the effect of moderate dietary salt reductions on future cardiac disease rates, several members of the American Thyroid Association, concerned about the subsequent potential reduction in availability of iodine, have responded with a letter in the current issue of the NEJM (Vol. 362 No. 23 pp 2224-2226).
Belkin today announced a strategic partnership with Peerless Industries, Inc., a designer, manufacturer and distributor of audio-visual solutions. The partnership will initially yield the PeerCare Electronic Medical Records (EMR) Hybrid Cart, fitted with a unique modular battery power system.
In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) today launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph William Vincent, OD 523 9th St S, Great Falls, MT 59405-2113 Ph: (307) 679-6832 | Dr Joseph William Vincent, OD 523 9th St S, Great Falls, MT 59405-2113 Ph: (307) 679-6832 |
News Archive
The fixed combination of the two drugs insulin degludec and liraglutide (trade name: Xultophy) has been approved since June 2015 also in adults with type 2 diabetes mellitus when oral antidiabetics (OADs) combined with a GLP-1 receptor agonist do not provide adequate glycaemic control. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether this fixed combination offers an added benefit over the appropriate comparator therapy (ACT).
Following publication of an article in the February 18 issue of the New England Journal of Medicine (Vol. 362 No. 7 pp 590-599) by Bibbins-Domingo, et al. that projected the effect of moderate dietary salt reductions on future cardiac disease rates, several members of the American Thyroid Association, concerned about the subsequent potential reduction in availability of iodine, have responded with a letter in the current issue of the NEJM (Vol. 362 No. 23 pp 2224-2226).
Belkin today announced a strategic partnership with Peerless Industries, Inc., a designer, manufacturer and distributor of audio-visual solutions. The partnership will initially yield the PeerCare Electronic Medical Records (EMR) Hybrid Cart, fitted with a unique modular battery power system.
In a major effort to speed treatment and cures for pediatric brain tumors and cancer, the Children's Brain Tumor Foundation (CBTF) today launched the initial phase of a tissue bank consortium designed to jump-start meaningful analyses that could lead to treatment and cures for these types of cancer, where survival rates are unacceptably low and neurocognitive and other damage is posed by today's treatment options.
› Verified 9 days ago
Dr. Robert J Sherer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3226 10th Ave S, Great Falls, MT 59405 Phone: 406-205-3552 Fax: 406-952-0019 | |
Jordan Neiffer, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 523 9th St S, Great Falls, MT 59405 Phone: 406-727-9160 | |
Dr. James W Reeves, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 11 5th St N, Suite 101, Great Falls, MT 59401 Phone: 406-761-6841 Fax: 406-454-0609 | |
Central Montana Eyecare Pc Optometrist Medicare: Medicare Enrolled Practice Location: 2012 14th St Sw, Great Falls, MT 59404 Phone: 406-453-1900 Fax: 406-453-1700 | |
Dr. Joshua A Hager, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 509 2nd Ave N, Great Falls, MT 59401 Phone: 406-452-9507 | |
Dr. Audra Nicole Sexton, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3000 15th Ave S, Great Falls, MT 59405 Phone: 406-454-2171 | |
Dr. Kenneth A Ethier, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 1525 10th Ave S, Great Falls, MT 59405 Phone: 406-791-5139 |